STABILISING EXCIPIENT FOR INACTIVATED WHOLE-VIRUS VACCINES
The invention relates to a vaccine composition containing: (a) inactivated whole virus; and (b) a stabilising excipient comprising (i) a buffer solution, (ii) a mixture of essential and non-essential amino acids, (iii) a disaccharide, (iv) a polyol, (v) a chelating agent, (vi) urea or a urea derivat...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a vaccine composition containing: (a) inactivated whole virus; and (b) a stabilising excipient comprising (i) a buffer solution, (ii) a mixture of essential and non-essential amino acids, (iii) a disaccharide, (iv) a polyol, (v) a chelating agent, (vi) urea or a urea derivative, and (vii) a non-ionic surfactant.
La invención se relaciona a una composición de vacuna que contiene: (a) virus entero inactivado; y (b) un excipiente estabilizante que comprende (i) una solución reguladora, (ii) una mezcla de aminoácidos esenciales y no esenciales, (iii) un disacárido, (iv) un poliol, (v) un agente quelante, (vi) urea o un derivado de urea y (vii) un surfactante no iónico. |
---|